Characterisation of Early Mucosal and Neuronal Lesions Following Shigella flexneri Infection in Human Colon
Open Access
- 5 March 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 4 (3), e4713
- https://doi.org/10.1371/journal.pone.0004713
Abstract
Shigella, an enteroinvasive bacteria induces a major inflammatory response responsible for acute rectocolitis in humans. However, early effect of Shigella flexneri (S. flexneri) infection upon the human mucosa and its microenvironement, in particular the enteric nervous system, remains currently unknown. Therefore, in this study, we sought to characterize ex vivo the early events of shigellosis in a model of human colonic explants. In particular, we aimed at identifying factors produced by S. flexneri and responsible for the lesions of the barrier. We also aimed at determining the putative lesions of the enteric nervous system induced by S. flexneri. We first showed that, following 3 h of infection, the invasive but not the non-invasive strain of S. flexneri induced significant desquamation of the intestinal epithelial barrier and a reduction of epithelial height. These changes were significantly reduced following infection with SepA deficient S. flexneri strains. Secondly, S. flexneri induced rapid neuronal morphological alterations suggestive of cell death in enteric submucosal neurones. These alterations were associated with a significant increase in the proportion of vasoactive intestinal peptide (VIP) immunoreactive (IR) neurons but not in total VIP levels. The NMDA receptor antagonist MK-801 blocked neuronal morphological changes induced by S. flexneri, but not the increase in the proportion of VIP-IR. This human explant model can be used to gain better insight into the early pathogenic events following S. flexneri infection and the mechanisms involved.Keywords
This publication has 24 references indexed in Scilit:
- Molecular Pathogenesis ofShigellaspp.: Controlling Host Cell Signaling, Invasion, and Death by Type III SecretionClinical Microbiology Reviews, 2008
- Axonal transport and neurodegenerative diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2006
- Shigellosis: An Old Disease in New Clothes?PLoS Medicine, 2006
- Protective Effect of Proteinase-Activated Receptor 2 Activation on Motility Impairment and Tissue Damage Induced by Intestinal Ischemia/Reperfusion in RodentsThe American Journal of Pathology, 2006
- A role for proteinase-activated receptor-1 in inflammatory bowel diseasesJCI Insight, 2006
- Human mucosa/submucosa interactions during intestinal inflammation: involvement of the enteric nervous system in interleukin-8 secretionCellular Microbiology, 2005
- CLINICAL RELEVANCE OF PROTEINASE ACTIVATED RECEPTORS (PARS) IN THE GUTGut, 2005
- War and peace at mucosal surfacesNature Reviews Immunology, 2004
- The human enteric nervous systemNeurogastroenterology & Motility, 2004
- Rupture, invasion and inflammatory destruction of the intestinal barrier byShigella, making sense of prokaryote–eukaryote cross-talksFEMS Microbiology Reviews, 2001